IDEXX Laboratories' oncology panel and share buybacks boost outlook. Read why IDXX stock is upgraded to buy with growth ...

IDEXX Laboratories, Inc. develops ... Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers ...

Our nearly double-digit premium instrument installed base growth, is driven by robust new placements across chemistry, hematology, and SediVue platforms, as well as the first placements of IDEXX ...

Presentation Operator Good morning, and welcome to the IDEX Laboratories 4th-Quarter 2024 Earnings Conference Call. As a reminder, today's conference is being recorded. Participating in the call ...

IDEXX Laboratories, Inc. IDXX is well-poised to grow in the upcoming quarters due to the performance of its CAG (Companion Animal Group) Diagnostics business. The consistent growth in ...

IDEXX Laboratories has a 52 week low of $398.50 and a 52 week high of $562.25. The company has a current ratio of 1.31, a quick ratio of 0.95 and a debt-to-equity ratio of 0.28. Insiders Place ...

Stocks Trim Losses On Mexico Tariff Delay, Gold Extends Records, Tesla Sinks 6%: What's Driving Markets Monday? Wall Street bounced back after President Donald Trump and Mexican President Claudia ...

In a report released yesterday, Mark Massaro from BTIG reiterated a Buy rating on Idexx Laboratories (IDXX – Research Report), with a price target of $530.00. The company’s shares closed ...

Delving into IDEXX Laboratories's Background Idexx Laboratories ... kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site ...